NASDAQ:DRIO
DarioHealth Corp Stock News
$1.57
+0.0500 (+3.29%)
At Close: May 03, 2024
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board of Di
Intersect ENT (NASDAQ:XENT) versus DarioHealth (NASDAQ:DRIO) Financial Review
01:46am, Wednesday, 24'th Jun 2020
Intersect ENT (NASDAQ:XENT) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their di
Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions
12:30pm, Thursday, 18'th Jun 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of d
DarioHealth Announces Participation in the Virtual Going Digital: Behavioral Health Tech Summit
12:30pm, Wednesday, 17'th Jun 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that Omar Manejwala, M.D., Chief Medical Officer, will present at the virtual Going Digital: Beha
DarioHealth (NASDAQ:DRIO) Receives News Impact Score of -3.53
05:52am, Tuesday, 16'th Jun 2020
News articles about DarioHealth (NASDAQ:DRIO) have been trending very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing
DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) company, presented the results of two new studies at the American Diabetes Association's (ADA) 80th Scientific Sessions th
DarioHealth Announces Two Remote Patient Monitoring (RPM) Agreements and Commences Enrollment
12:30pm, Thursday, 11'th Jun 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has signed its first two remote patient monitoring (RPM) agreements. Remote pati
Four big firms expected to enter the blue-chip FTSE 100 index
11:36am, Thursday, 04'th Jun 2020
B&Q owner Kingfisher and home repairs giant Homeserve are the other two business that are predicted to enter the share index.
News Flash: 2 Analysts Think DarioHealth Corp. (NASDAQ:DRIO) Earnings Are Under Threat
11:16am, Thursday, 14'th May 2020
The analysts covering DarioHealth Corp. (NASDAQ:DRIO) delivered a dose of negativity to shareholders today, by making...
Recap: DarioHealth Q1 Earnings
11:06am, Tuesday, 12'th May 2020
Shares of DarioHealth (NASDAQ:DRIO) remained unaffected at $7.95 after the company reported Q1 results.Quarterly Results Earnings per share fell 946.67% year over year to ($1.57), which missed the est
DarioHealth Reports First Quarter 2020 Results
11:00am, Tuesday, 12'th May 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter 2020 and provided a corporate and commercial update.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, lim
DarioHealth poaches former Catasys execs, launches behavioral health coaching
10:45pm, Tuesday, 05'th May 2020
DarioHealth, a digital health company focused on patients with diabetes and hypertension, rolled out behavioral health coaching for its users.
